Lexicon Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Lexicon Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 07, 2026 THE WOODLANDS, Texas, Jan. 07, 2026 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15 at 12:00 p.m. PT (3:00 p.m. […]

DeFi Development Corp. Releases 2025 Year in Review Highlighting Breakout Growth and Solana Treasury Leadership

DeFi Development Corp. Releases 2025 Year in Review Highlighting Breakout Growth and Solana Treasury Leadership GlobeNewswire January 07, 2026 BOCA RATON, FL, Jan. 07, 2026 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced the release of

Leviathan Metals Corp. Announces Strategic Advances and Outlook for 2026

Leviathan Metals Corp. Announces Strategic Advances and Outlook for 2026 GlobeNewswire January 07, 2026 VANCOUVER, British Columbia, Jan. 07, 2026 (GLOBE NEWSWIRE) — Leviathan Metals Corp. (the “Company” or “Leviathan”) (LVX – TSXV, LVXFF – OTCQB, 0GP – FSE) today provides a recap of its key achievements in 2025 and an outline of its plans

Reliance Global Group Signs Term Sheet to Acquire Majority Stake in Israeli AI Diagnostic Company, Scentech, Positioning for Entry into the Multi-Billion Dollar Early Disease Detection Market

Reliance Global Group Signs Term Sheet to Acquire Majority Stake in Israeli AI Diagnostic Company, Scentech, Positioning for Entry into the Multi-Billion Dollar Early Disease Detection Market GlobeNewswire January 07, 2026 Transaction structured to achieve majority ownership through performance-based clinical and regulatory milestones Marks first strategic acquisition for new division–Ezra International Group Lakewood, NJ, Jan.

Defiance Launches PLU: The First 2X Long ETF for Planet Labs PBC

Defiance Launches PLU: The First 2X Long ETF for Planet Labs PBC GlobeNewswire January 07, 2026 MIAMI, Jan. 07, 2026 (GLOBE NEWSWIRE) — Defiance ETFs is proud to announce the launch of the Defiance Daily Target 2X Long PL ETF (PLU), expanding its suite of single-stock leveraged ETFs designed for active traders seeking amplified exposure

KraneShares Launches KIQQ ETF With Dynamic Hedging Strategies & Option Income Tied To The Nasdaq-100(R)

KraneShares Launches KIQQ ETF With Dynamic Hedging Strategies & Option Income Tied To The Nasdaq-100(R) GlobeNewswire January 07, 2026 NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — KraneShares, a leading provider of innovative exchange-traded funds (ETFs), today announced the launch of the KraneShares InspereX Nasdaq Dynamic Buffered High Income Index ETF (Ticker: KIQQ). KIQQ is

Gaia Premieres New Series StarCast Weekly Featuring Renowned Evolutionary Astrologer Richard James

Gaia Premieres New Series StarCast Weekly Featuring Renowned Evolutionary Astrologer Richard James James Will Help Viewers Navigate Their Daily Lives Based on the Upcoming Celestial Energies Every Week GlobeNewswire January 07, 2026 BOULDER, Colo., Jan. 07, 2026 (GLOBE NEWSWIRE) — Gaia (NASDAQ: GAIA) – the world's largest streaming and community platform dedicated to personal transformation,

InterDigital to Present at 28th Annual Needham Growth Conference

InterDigital to Present at 28th Annual Needham Growth Conference GlobeNewswire January 07, 2026 WILMINGTON, Del., Jan. 07, 2026 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced that the company will be presenting at the 28th Annual Needham Growth Conference on Wednesday, January 14th, 2026,

EOM Pharmaceutical Holdings Reports Promising Preclinical Results and Provides an Update on EOM613 and EOM147

EOM Pharmaceutical Holdings Reports Promising Preclinical Results and Provides an Update on EOM613 and EOM147 GlobeNewswire January 07, 2026 Clinical Trials in Cancer Cachexia, Inflammatory Bowel Disease and Retinal Disorders are Planned MONTVALE, N. J., Jan. 07, 2026 (GLOBE NEWSWIRE) — EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) (“EOM”) an innovative biotechnology company focused on developing

BTCS Preannounces Record Revenue for 2025 and Issues Annual Shareholder Letter

BTCS Preannounces Record Revenue for 2025 and Issues Annual Shareholder Letter GlobeNewswire January 07, 2026 Delivered record full-year unaudited revenue of approximately $16 million, a 290% increase Grew total assets by approximately 600% year over year and increased Ethereum holdings to more than 70,500 ETH as of December 31, 2025 WAYNE, Pa., Jan. 07, 2026

Scroll to Top